» Articles » PMID: 33186591

Assay for Advanced Glycation End Products Generating Intracellular Oxidative Stress Through Binding to Its Receptor

Overview
Journal Anal Biochem
Publisher Elsevier
Specialty Biochemistry
Date 2020 Nov 13
PMID 33186591
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Advanced glycation end products (AGEs) are a heterogenous group of glycation adducts on amino acids produced with sugars or dicarbonyls. Intracellular inflammation triggered by binding of AGEs to receptor for AGEs (RAGE) is linked to some chronic diseases. Here, we established a competitive assay format to comprehensively quantify AGEs which bound to RAGE. RAGE-binding activities of sugar- and dicarbonyl-derived AGEs were correlated with oxidative stress in cultured cells generated by the respective AGEs, suggesting that this would be a promising method for evaluating AGEs which could affect cellular functions despite limited information on individual glycation adducts.

Citing Articles

Ge-Gen-Qin-Lian decoction alleviates the symptoms of type 2 diabetes mellitus with inflammatory bowel disease via regulating the AGE-RAGE pathway.

Li Z, Zhao Z, Chen S, Wang X, Wang D, Nie X BMC Complement Med Ther. 2024; 24(1):225.

PMID: 38858747 PMC: 11163797. DOI: 10.1186/s12906-024-04526-x.


Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes.

Bansal S, Burman A, Tripathi A World J Diabetes. 2023; 14(8):1146-1162.

PMID: 37664478 PMC: 10473940. DOI: 10.4239/wjd.v14.i8.1146.


Advanced Glycation End Products and Their Effect on Vascular Complications in Type 2 Diabetes Mellitus.

Lee J, Yun J, Ko S Nutrients. 2022; 14(15).

PMID: 35956261 PMC: 9370094. DOI: 10.3390/nu14153086.


Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs.

Twarda-Clapa A, Olczak A, Bialkowska A, Koziolkiewicz M Cells. 2022; 11(8).

PMID: 35455991 PMC: 9029922. DOI: 10.3390/cells11081312.